|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
46
|
|
pubmed:dateCreated |
2006-1-26
|
|
pubmed:abstractText |
To determine the utility of interferon (IFN)-alpha production capacity in patients with hepatitis C virus (HCV) infection for the measurement of immuno-surveillance potential and for the early detection of hepatocellular carcinoma (HCC) by investigating the Sendai virus (HVJ) stimulated IFN-alpha production capacity of patients with HCV infection.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
1007-9327
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
14
|
|
pubmed:volume |
11
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
7330-4
|
|
pubmed:dateRevised |
2010-3-23
|
|
pubmed:meshHeading |
pubmed-meshheading:16437637-Adult,
pubmed-meshheading:16437637-Aged,
pubmed-meshheading:16437637-Carcinoma, Hepatocellular,
pubmed-meshheading:16437637-Case-Control Studies,
pubmed-meshheading:16437637-Female,
pubmed-meshheading:16437637-Hepatitis C, Chronic,
pubmed-meshheading:16437637-Humans,
pubmed-meshheading:16437637-Interferon-alpha,
pubmed-meshheading:16437637-Leukocytes,
pubmed-meshheading:16437637-Liver Cirrhosis,
pubmed-meshheading:16437637-Liver Neoplasms,
pubmed-meshheading:16437637-Male,
pubmed-meshheading:16437637-Middle Aged,
pubmed-meshheading:16437637-Risk Factors,
pubmed-meshheading:16437637-Sendai virus,
pubmed-meshheading:16437637-Time Factors
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Impairment of IFN-alpha production capacity in patients with hepatitis C virus and the risk of the development of hepatocellular carcinoma.
|
|
pubmed:affiliation |
Louis Pasteur Center for Medical Research, 103-5 Tanaka-monzen-cho, Sakyo-ku, Kyoto 606, Japan. kazukouno@louis-pasteur.or.jp
|
|
pubmed:publicationType |
Journal Article,
In Vitro,
Research Support, Non-U.S. Gov't
|
